Sign In
Section Navigation
Common TitleGS-141-1219
Official Title A Phase 1b Randomized, Double-Blinded, Sequential Cohort Placebo-Controlled Study of the Safety, Pharmacokinetics, and Antiviral Activity of Bictegravir (GS-9883) in HIV-1 Infected Subjects
Phase Phase I
ClinicalTrials.gov NCT02275065
Categories Treatment-ExperiencedMonotherapy
Funding
IndustryGilead Sciences
References
  • Gallant JE, Thompson M, DeJesus E, et al. Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults. J Acquir Immune Defic Syndr. 2017;75:61-66.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.